Cardiology, Clinical Immunology, Clinical Pharmacology, Critical Care,
Gastroenterology, General Internal Medicine, Geriatric Medicine,
|PAUL ADAMS, MD, FRCPC, Professor of Medicine, Chair, Division of Gastroenterology|
Dr. Adams received his medical degree from Queen’s University, Canada in 1980. After completing an internship and residency training in Toronto, he did further training at Mount Sinai Hospital, New York and completed a Fellowship in Gastroenterology at the University of California at San Francisco (UCSF). He also worked at the Liver Research Unit of the Royal Brisbane Hospital, Australia. He is currently Professor and Chief of the Division of Gastroenterology at the University of Western Ontario in London, Canada. His research interest is the study of genetic hemochromatosis. He is currently the Editor of the Canadian Journal of Gastroenterology.
|MELANIE BEATON, MD, FRCPC, Assistant Professor|
Melanie Beaton completed her MD at the University of Ottawa and residency training in Internal Medicine and Gastroenterology at the University of Western Ontario. After completing her Gastroenterology training she went on to complete a research fellowship in Iron Metabolism and Non-alcoholic Fatty Liver Disease in Brisbane, Australia. She returned to London and joined the Department of Medicine in the Division of Gastroenterology. Her clinical practice encompasses general gastroenterology. She has a research interest in the management of non-alcoholic fatty liver disease and drug disposition in this condition.
Hepatic Drug Metabolism
Non-Alcoholic Fatty Liver Disease
|BRIAN FEAGAN, MD, FRCPC, Professor |
Dr. Feagan is a gastroenterologist and clinical epidemiologist who is the CEO and Senior Scientific Director of Robarts Clinical Trials Inc at the Robarts Research Institute, London, Ontario, Canada. His research interest is in the design and implementation of randomized controlled trials.
His most significant research contributions have resulted in findings of multi-center clinical trials in which treatment of inflammatory bowel disease have been identified.
A more recent research interest is the application of cluster randomization trials in the evaluation of health policy. This research is highly relevant to health-care providers who are responsible for the development of comprehensive disease management programs.
Randomized controlled trials
|REENA KHANNA, MD, FRCPC, Assistant Professor|
Reena Khanna completed a BSc Honours with high distinction at the University of Toronto. She then studied medicine and internal medicine at UWO before moving to McMaster for training in gastroenterology. She served as chief resident during both these residences. Following graduation in gastroenterology, she completed an IBD fellowship at the Cleveland Clinic, then training in international IBD clinical trials at Robarts/UWO. She is currently an Assistant Professor at the University of Western Ontario and is completing an MSc in clinical epidemiology at McMaster University. Her clinical and research interest is inflammatory bowel disease.
|ADAM RAHMAN, MD, FRCPC, Assistant Professor|
My clinical and research interest are focused on clinical nutrition.
After training in internal medicine and gastroenterology, I completed advanced training in clinical nutrition at the University of Chicago.
I subsequently trained in critical medicine at the University of Toronto at Sunnybrook Health Sciences Centre focusing on phamaco-nutrition in critically ill patients. I am currently completing my Master’s of Clinical Epidemiology at the University of Toronto.